From ingredients to devices: what BON Natural Life Limited’s apple mask means for medical aesthetics innovation
Explore how BON Natural Life Limited’s bio-electronic apple polyphenol mask could reshape medical aesthetics if clinical data holds up.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
Life Spine strengthens ProLift’s long-term viability as MRI compatibility becomes a procurement baseline
Life Spine confirms MR Conditional status for ProLift. Find out why MRI compatibility now defines spine implant viability rather than differentiation.
Medical Devices & Diagnostics
Why Project Santa Fe Foundation and Virchow Medical are testing a proactive future for oncology diagnostics
Project Santa Fe Foundation and Virchow Medical are redefining oncology diagnostics through proactive analytics. Find out what this changes for labs and clinicians.
Medical Devices & Diagnostics
Next-generation SIGNA MRI gains FDA nod, sharpening GE HealthCare’s imaging strategy
GE HealthCare secures FDA clearance for next-generation SIGNA MRI. Explore clinical impact, workflow gains, and market implications.
Medical Devices & Diagnostics
Dror Ortho-Design advances U.S. commercialization with next-generation ZSmile Platform
Dror Ortho-Design secures FDA clearance for ZSmile. Explore what pneumatic aligners mean for orthodontic innovation and adoption.
Medical Devices & Diagnostics
Profusa Lumee Oxygen gains pre-approval orders as EU MDR decision looms
Profusa secures Lumee Oxygen orders ahead of EU MDR clearance. Discover what this means for CLTI monitoring and 2026 commercialization.
Medical Devices & Diagnostics
STAAR Surgical advances EVO ICL adoption as FDA approval reframes high-myopia treatment economics
FDA expands EVO ICL use to ages 21–60. Discover what this means for refractive surgery, safety data, and the shift away from laser vision correction.
Medical Devices & Diagnostics
What GE HealthCare’s $35m BARDA expansion reveals about the future of trauma imaging
GE HealthCare expands its BARDA-backed artificial intelligence ultrasound program. Discover what this changes for trauma care and emergency preparedness.
Medical Devices & Diagnostics
How UNC Health’s Mevion deployment reflects a reset in proton therapy economics
UNC Health selects Mevion’s compact proton system. Discover what this means for proton therapy economics, workflows, and academic cancer care.
Medical Devices & Diagnostics
Instanosis secures FDA breakthrough status for xylazine urine test as overdose care faces new diagnostic gaps
Instanosis wins FDA breakthrough status for its xylazine urine test. Find out why this matters for overdose diagnostics and what challenges remain.